2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one

C109H127ClN18O10 — CID 161296509

IUPAC2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one
SMILESCN1C(=O)[C@@](CCC2CCCCC2)(C[C@H]2CCC[C@@H](NC(=O)c3cc[n+]([O-])cc3)C2)N=C1N.CN1C(=O)[C@@](CCc2ccccc2)(C[C@H]2CCC[C@@H](Nc3ccc4ccccc4n3)C2)N=C1N.NC1=NC(c2cccc(-c3cccc(Cl)c3)c2)(C2CC2)C(=O)N1CCOCCO.NC1=NC(c2ccccc2)(c2cccc(-c3cccnc3)c2)C(=O)N1CC1CCN(C(=O)COc2ccccc2)CC1
InChIInChI=1S/C34H33N5O3.C28H33N5O.C25H37N5O3.C22H24ClN3O3/c35-33-37-34(28-11-3-1-4-12-28,29-13-7-9-26(21-29)27-10-8-18-36-22-27)32(41)39(33)23-25-16-19-38(20-17-25)31(40)24-42-30-14-5-2-6-15-30;1-33-26(34)28(32-27(33)29,17-16-20-8-3-2-4-9-20)19-21-10-7-12-23(18-21)30-25-15-14-22-11-5-6-13-24(22)31-25;1-29-23(32)25(28-24(29)26,13-10-18-6-3-2-4-7-18)17-19-8-5-9-21(16-19)27-22(31)20-11-14-30(33)15-12-20;23-19-6-2-4-16(14-19)15-3-1-5-18(13-15)22(17-7-8-17)20(28)26(21(24)25-22)9-11-29-12-10-27/h1-15,18,21-22,25H,16-17,19-20,23-24H2,(H2,35,37);2-6,8-9,11,13-15,21,23H,7,10,12,16-19H2,1H3,(H2,29,32)(H,30,31);11-12,14-15,18-19,21H,2-10,13,16-17H2,1H3,(H2,26,28)(H,27,31);1-6,13-14,17,27H,7-12H2,(H2,24,25)/t;21-,23+,28+;19-,21+,25+;/m.00./s1
InChIKeyVHAUNDGNRDZQKV-YDZHBXEZSA-N
MW1884.78 g/mol
LogP14.88
Rot. Bonds30

About 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one

2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one (PubChem CID 161296509) has the molecular formula C109H127ClN18O10 and a molecular weight of 1884.78 g/mol. Its IUPAC name is 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one.

Molecular Properties

Compound Name2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one
PubChem CID161296509
Molecular FormulaC109H127ClN18O10
Molecular Weight1884.78 g/mol
Exact Mass1882.97
IUPAC Name2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one
SMILESCN1C(=O)[C@@](CCC2CCCCC2)(C[C@H]2CCC[C@@H](NC(=O)c3cc[n+]([O-])cc3)C2)N=C1N.CN1C(=O)[C@@](CCc2ccccc2)(C[C@H]2CCC[C@@H](Nc3ccc4ccccc4n3)C2)N=C1N.NC1=NC(c2cccc(-c3cccc(Cl)c3)c2)(C2CC2)C(=O)N1CCOCCO.NC1=NC(c2ccccc2)(c2cccc(-c3cccnc3)c2)C(=O)N1CC1CCN(C(=O)COc2ccccc2)CC1
InChIInChI=1S/C34H33N5O3.C28H33N5O.C25H37N5O3.C22H24ClN3O3/c35-33-37-34(28-11-3-1-4-12-28,29-13-7-9-26(21-29)27-10-8-18-36-22-27)32(41)39(33)23-25-16-19-38(20-17-25)31(40)24-42-30-14-5-2-6-15-30;1-33-26(34)28(32-27(33)29,17-16-20-8-3-2-4-9-20)19-21-10-7-12-23(18-21)30-25-15-14-22-11-5-6-13-24(22)31-25;1-29-23(32)25(28-24(29)26,13-10-18-6-3-2-4-7-18)17-19-8-5-9-21(16-19)27-22(31)20-11-14-30(33)15-12-20;23-19-6-2-4-16(14-19)15-3-1-5-18(13-15)22(17-7-8-17)20(28)26(21(24)25-22)9-11-29-12-10-27/h1-15,18,21-22,25H,16-17,19-20,23-24H2,(H2,35,37);2-6,8-9,11,13-15,21,23H,7,10,12,16-19H2,1H3,(H2,29,32)(H,30,31);11-12,14-15,18-19,21H,2-10,13,16-17H2,1H3,(H2,26,28)(H,27,31);1-6,13-14,17,27H,7-12H2,(H2,24,25)/t;21-,23+,28+;19-,21+,25+;/m.00./s1
InChIKeyVHAUNDGNRDZQKV-YDZHBXEZSA-N
XLogP14.88
TPSA387.61 Ų
H-Bond Donors7
H-Bond Acceptors21
Rotatable Bonds30
Heavy Atoms138
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001884.78
LogP ≤ 514.88
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'N_oxide', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one?
The IUPAC name of 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one (CID 161296509) is 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one.
What is the SMILES notation for 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one?
The canonical SMILES for 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one is CN1C(=O)[C@@](CCC2CCCCC2)(C[C@H]2CCC[C@@H](NC(=O)c3cc[n+]([O-])cc3)C2)N=C1N.CN1C(=O)[C@@](CCc2ccccc2)(C[C@H]2CCC[C@@H](Nc3ccc4ccccc4n3)C2)N=C1N.NC1=NC(c2cccc(-c3cccc(Cl)c3)c2)(C2CC2)C(=O)N1CCOCCO.NC1=NC(c2ccccc2)(c2cccc(-c3cccnc3)c2)C(=O)N1CC1CCN(C(=O)COc2ccccc2)CC1.
What is the InChIKey of 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one?
The InChIKey is VHAUNDGNRDZQKV-YDZHBXEZSA-N. The full InChI is InChI=1S/C34H33N5O3.C28H33N5O.C25H37N5O3.C22H24ClN3O3/c35-33-37-34(28-11-3-1-4-12-28,29-13-7-9-26(21-29)27-10-8-18-36-22-27)32(41)39(33)23-25-16-19-38(20-17-25)31(40)24-42-30-14-5-2-6-15-30;1-33-26(34)28(32-27(33)29,17-16-20-8-3-2-4-9-20)19-21-10-7-12-23(18-21)30-25-15-14-22-11-5-6-13-24(22)31-25;1-29-23(32)25(28-24(29)26,13-10-18-6-3-2-4-7-18)17-19-8-5-9-21(16-19)27-22(31)20-11-14-30(33)15-12-20;23-19-6-2-4-16(14-19)15-3-1-5-18(13-15)22(17-7-8-17)20(28)26(21(24)25-22)9-11-29-12-10-27/h1-15,18,21-22,25H,16-17,19-20,23-24H2,(H2,35,37);2-6,8-9,11,13-15,21,23H,7,10,12,16-19H2,1H3,(H2,29,32)(H,30,31);11-12,14-15,18-19,21H,2-10,13,16-17H2,1H3,(H2,26,28)(H,27,31);1-6,13-14,17,27H,7-12H2,(H2,24,25)/t;21-,23+,28+;19-,21+,25+;/m.00./s1.
What are the key properties of 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one?
2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one has a molecular weight of 1884.78 g/mol, XLogP of 14.88, 30 rotatable bonds, 7 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopropyl-3-[2-(2-hydroxyethoxy)ethyl]imidazol-4-one;N-[(1R,3S)-3-[[(4R)-2-amino-4-(2-cyclohexylethyl)-1-methyl-5-oxoimidazol-4-yl]methyl]cyclohexyl]-1-oxidopyridin-1-ium-4-carboxamide;(5R)-2-amino-3-methyl-5-(2-phenylethyl)-5-[[(1S,3R)-3-(quinolin-2-ylamino)cyclohexyl]methyl]imidazol-4-one;2-amino-3-[[1-(2-phenoxyacetyl)piperidin-4-yl]methyl]-5-phenyl-5-(3-pyridin-3-ylphenyl)imidazol-4-one is sourced from PubChem (CID 161296509), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).